PureTech Health Plc - ADR Stock News
$19.10
2.10%
today
Nasdaq,
Dec 30, 07:52 pm CET
PureTech Health Plc - ADR Stock News
Neutral
Business Wire
●
15 days ago
BOSTON--(BUSINESS WIRE)--PureTech's Deupirfenidone Slowed Lung Function Decline in People w/ IPF, Achieving the Primary & Key Secondary Endpoints in ELEVATE IPF Phase 2b Trial.
Neutral
Business Wire
●
19 days ago
BOSTON--(BUSINESS WIRE)--PureTech Founded Entity Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP Annual Meeting 2024.
Neutral
Business Wire
●
22 days ago
BOSTON--(BUSINESS WIRE)--PureTech Presents Data for LYT-200 (anti-galectin-9 monoclonal antibody) for Relapsed/Refractory AML/MDS at the 2024 ASH Annual Meeting.
Neutral
Business Wire
●
about one month ago
BOSTON--(BUSINESS WIRE)--PureTech Founded Entity Seaport Therapeutics Adds Sandi Peterson to its Board of Directors.
Neutral
Business Wire
●
3 months ago
BOSTON--(BUSINESS WIRE)--PureTech to Present at CHEST 2024 Annual Meeting.
Neutral
Seeking Alpha
●
4 months ago
PureTech Health plc (NASDAQ:PRTC ) Q2 2024 Earnings Conference Call August 28, 2024 9:00 AM ET Company Participants Allison Mead Talbot - Head of Communications Bharatt Chowrira - CEO Eric Elenko - Co-Founder & President Conference Call Participants Lucy Codrington - Jefferies Thomas Smith - Leerink Partners Miles Dixon - Peel Hunt Operator Greetings, and welcome to the PureTech Health 2024 Hal...
Neutral
Business Wire
●
4 months ago
BOSTON--(BUSINESS WIRE)--PureTech Health plc – Half-Year Report.
Neutral
Business Wire
●
4 months ago
BOSTON--(BUSINESS WIRE)--PureTech Health: Notice of Half-Yearly Results.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
